Literature DB >> 26726303

Interaction of the core fragments of the LL-37 host defense peptide with actin.

Asaf Sol1, Guangshun Wang2, Edna Blotnick3, Radha Golla2, Gilad Bachrach1, Andras Muhlrad1.   

Abstract

Host defense peptides are effector molecules of the innate immunity that possess antimicrobial and health-promoting properties. Due to their potential therapeutic activities, host defense peptides are being explored as alternatives for antibiotics. The human LL-37 and its shorter, cost-effective, bactericidal core peptide derivates have been suggested for their therapeutic potential. Bacteria evade host defense peptides by proteolytic inactivation. Actin released from necrotized cells and abundant in infected sites was shown to bind and protect LL-37 from microbial proteolytic degradation, and to enable the peptide's antimicrobial action despite the presence of the proteases. Here, we characterized the interactions of the 10-13 residues long LL-37 core peptides with actin. We show that the LL-37 core peptides associate with actin with a lower affinity than that of LL-37. Their association with actin, which is very ionic strength sensitive, is mainly based on electrostatic interactions. Likewise, the antimicrobial activity against Escherichia coli of the minimal antimicrobial peptide KR-12 but not FK-13 nor LL-37 is also very sensitive to salts. In addition, the antimicrobial activity of the FK-13 core peptide is protected by actin against the tested bacterial proteases in a similar manner to that of LL-37, supporting its potential for therapeutic use.

Entities:  

Year:  2014        PMID: 26726303      PMCID: PMC4696493          DOI: 10.1039/C4RA13007C

Source DB:  PubMed          Journal:  RSC Adv        ISSN: 2046-2069            Impact factor:   3.361


  25 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

2.  Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.

Authors:  Xia Li; Yifeng Li; Huiyun Han; Donald W Miller; Guangshun Wang
Journal:  J Am Chem Soc       Date:  2006-05-03       Impact factor: 15.419

3.  Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action.

Authors:  Yosef Rosenfeld; Niv Papo; Yechiel Shai
Journal:  J Biol Chem       Date:  2005-11-17       Impact factor: 5.157

4.  In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria.

Authors:  H Altman; D Steinberg; Y Porat; A Mor; D Fridman; M Friedman; G Bachrach
Journal:  J Antimicrob Chemother       Date:  2006-05-10       Impact factor: 5.790

5.  Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Authors:  Asaf Sol; Yaniv Skvirsky; Rizan Nashef; Katya Zelentsova; Tal Burstyn-Cohen; Edna Blotnick; Andras Muhlrad; Gilad Bachrach
Journal:  J Biol Chem       Date:  2014-06-19       Impact factor: 5.157

6.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.

Authors:  Katrin Pütsep; Göran Carlsson; Hans G Boman; Mats Andersson
Journal:  Lancet       Date:  2002-10-12       Impact factor: 79.321

7.  Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans.

Authors:  Susanne F de Haar; Pieter S Hiemstra; Martijn T J M van Steenbergen; Vincent Everts; Wouter Beertsen
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

8.  The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin.

Authors:  Daniel J Weiner; Robert Bucki; Paul A Janmey
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12-30       Impact factor: 6.914

9.  An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.

Authors:  Isao Nagaoka; Hiroshi Tamura; Michimasa Hirata
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

10.  APD2: the updated antimicrobial peptide database and its application in peptide design.

Authors:  Guangshun Wang; Xia Li; Zhe Wang
Journal:  Nucleic Acids Res       Date:  2008-10-28       Impact factor: 16.971

View more
  5 in total

1.  Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model.

Authors:  Dilan Khalili; Christina Kalcher; Stefan Baumgartner; Ulrich Theopold
Journal:  J Innate Immun       Date:  2021-05-17       Impact factor: 7.349

2.  Actin and DNA Protect Histones from Degradation by Bacterial Proteases but Inhibit Their Antimicrobial Activity.

Authors:  Asaf Sol; Yaniv Skvirsky; Edna Blotnick; Gilad Bachrach; Andras Muhlrad
Journal:  Front Microbiol       Date:  2016-08-09       Impact factor: 5.640

3.  Histones bundle F-actin filaments and affect actin structure.

Authors:  Edna Blotnick; Asaf Sol; Andras Muhlrad
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

4.  Interactions of histatin-3 and histatin-5 with actin.

Authors:  Edna Blotnick; Asaf Sol; Gilad Bachrach; Andras Muhlrad
Journal:  BMC Biochem       Date:  2017-03-06       Impact factor: 4.059

5.  Targeted Delivery of Miconazole Employing LL37 Fragment Mutant Peptide CKR12-Poly (Lactic-Co-Glycolic) Acid Polymeric Micelles.

Authors:  Takeshi Mori; Miyako Yoshida; Mai Hazekawa; Daisuke Ishibashi; Yoshiro Hatanaka; Rie Kakehashi; Makoto Nakagawa; Toshihiro Nagao; Miki Yoshii; Honami Kojima; Rio Uno; Takahiro Uchida
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.